The President of the European Commission Ursula von der Leyen, February 10, 2021. -
Johanna Geron / AP / SIPA
The European Commission will launch a program on Wednesday intended to study changes in Covid-19, reveals Commission President Ursula von der Leyen in an interview with Les
Echos
to be published on Tuesday.
Called "Hera incubator", the new program "will bring together laboratories, health authorities, scientists, and the European Commission, with significant dedicated funds", she says, without specifying the amounts.
"As of now, and in parallel with efforts on current vaccines, we must help manufacturers to develop production capacities" for "second generation" vaccines, further details the manager in this interview, explaining that "these mutations worry us a lot. ".
Expedited procedures
Brussels had already announced its intention to launch a new European agency, the Health Emergency Response Authority (HERA), in order to fight against future pandemics and to better coordinate between the Twenty-Seven.
Regarding the marketing of new vaccines able to better respond to variants of Covid-19, the European Health Commissioner announced on Sunday an acceleration of the authorization procedure by the European Medicines Agency (EMA).
The president of the European executive also calls in this interview with Les
Echos
to "develop more systematic partnerships between laboratories, with controlled sharing of licenses, beyond the sole stage of bottling".
Politics
European Commission: Ursula Von der Leyen, "the perfect scapegoat" on the vaccine strategy against Covid-19?
Society
Vaccination: The Europeans were not "good enough" on the investment, according to Clément Beaune
World
European Commission
Covid 19
Coronavirus
Europe